Page 81 - 《中国药房》2023年4期

positive/HER2 negative breast cancer：discrete choice ex‐ （5）：812-817.
periment and best-worst scaling[J]. Patient Prefer Adhe- [26] KAPLAN R M，BUSH J W，BERRY C C. Health status：
rence，2020，14：2201-2214. types of validity and the index of well-being[J]. Health
[14] ZENG X Y，SUI M J，LIU B，et al. Measurement proper‐ Serv Res，1976，11（4）：478-507.
ties of the EQ-5D-5L and EQ-5D-3L in six commonly [27] BRADLYN A S，HARRIS C V，WARNER J E，et al. An
diagnosed cancers[J]. Patient，2021，14（2）：209-222. investigation of the validity of the quality of well-being
[15] GOLICKI D，MŁYŃCZAK K. Measurement properties of scale with pediatric oncology patients[J]. Health Psychol，
the EQ-5D-Y：a systematic review[J/OL]. Value Health， 1993，12（3）：246-250.
2022[2022-09-10]. http：//dx. doi. org/10.1016/j. jval. 2022. [28] SINTONEN H. The 15D instrument of health-related qua-
05.013. lity of life：properties and applications[J]. Ann Med，2001，
[16] 沈安乐，张顺国，罗南，等. EQ-5D-Y用于评价血液肿瘤 33（5）：328-336.
儿童健康相关生命质量的可行性与效度分析[J]. 中国药 [29] NGOC THI DANG D，NGOC THI NGUYEN L，THI
师，2020，23（4）：665-670. DANG N，et al. Quality of life in Vietnamese gastric can‐
[17] BRAZIER J E，MULHERN B J，BJORNER J B，et al. De‐ cer patients[J]. Biomed Res Int，2019，2019：7167065.
veloping a new version of the SF-6D health state classifi‐ [30] MÖRT S，SALANTERÄ S，MATOMÄKI J，et al. Self-
cation system from the SF-36v2：SF-6Dv2[J]. Med Care， reported health-related quality of life of children and ado‐
2020，58（6）：557-565. lescent survivors of extracranial childhood malignancies：
[18] NAHVIJOU A，SAFARI H，AMERI H. Psychometric a Finnish nationwide survey[J]. Qual Life Res，2011，20
properties of the SF-6Dv2 in an Iranian breast cancer （5）：787-797.
population[J]. Breast Cancer，2021，28（4）：937-943. [31] KING M T，COSTA D S J，AARONSON N K，et al. Erra‐
[19] XU R H，DONG D，LUO N，et al. Evaluating the psycho‐ tum to：QLU-C10D：a health state classification system
metric properties of the EQ-5D-5L and SF-6D among pa‐ for a multi-attribute utility measure based on the EORTC
tients with haemophilia[J]. Eur J Health Econ，2021，22 QLQ-C30[J]. Qual Life Res，2016，25（10）：2683.
（4）：547-557. [32] KING M T，NORMAN R，MERCIECA-BEBBER R，et
[20] TRAMONTANO A C，SCHRAG D L，MALIN J K，et al. al. The functional assessment of cancer therapy eight di‐
Catalog and comparison of societal preferences（utilities） mension（FACT-8D），a multi-attribute utility instrument
for lung cancer health states：results from the cancer care derived from the cancer-specific FACT-general（FACT-G）
outcomes research and surveillance（CanCORS）study[J]. quality of life questionnaire：development and Australian
Med Decis Making，2015，35（3）：371-387. value set[J]. Value Health，2021，24（6）：862-873.
[21] YOUSEFI M，NAJAFI S，GHAFFARI S，et al. Compari‐ [33] ROWEN D，BRAZIER J，YOUNG T，et al. Deriving a
son of SF-6D and EQ-5D scores in patients with breast preference-based measure for cancer using the EORTC
cancer[J]. Iran Red Crescent Med J，2016，18（5）：e23556. QLQ-C30[J]. Value Health，2011，14（5）：721-731.
[22] LOVRICS P J，CORNACCHI S D，BARNABI F，et al. [34] YOUNG T，YANG Y L，BRAZIER J E，et al. The first
The feasibility and responsiveness of the health utilities in‐ stage of developing preference-based measures：construc-
dex in patients with early-stage breast cancer：a prospec‐ ting a health-state classification using Rasch analysis[J].
tive longitudinal study[J]. Qual Life Res，2008，17（2）： Qual Life Res，2009，18（2）：253-265.
333-345. [35] GAMPER E M，HOLZNER B，KING M T，et al. Test-
[23] SHIMODA S，DE CAMARGO B，HORSMAN J，et al. retest reliability of discrete choice experiment for valua‐
Translation and cultural adaptation of health utilities index tions of QLU-C10D health states[J]. Value Health，2018，
（HUI）mark 2（HUI2 ）and mark 3（HUI3 ）with application 21（8）：958-966.
to survivors of childhood cancer in Brazil[J]. Qual Life [36] BULAMU N B，VISSAPRAGADA R，CHEN G，et al.
Res，2005，14（5）：1407-1412. Responsiveness and convergent validity of QLU-C10D
[24] FU L，TALSMA D，BAEZ F，et al. Measurement of and EQ-5D-3L in assessing short-term quality of life fol‐
health-related quality of life in survivors of cancer in lowing esophagectomy[J]. Health Qual Life Outcomes，
childhood in Central America：feasibility，reliability，and 2021，19（1）：233.
validity[J]. J Pediatr Hematol Oncol，2006，28（6）： [37] GAMPER E M，KING M T，NORMAN R，et al. The
331-341. EORTC QLU-C10D discrete choice experiment for cancer
[25] BORAN P，HORSMAN J，TOKUC G，et al. Translation patients：a first step towards patient utility weights[J]. J Pa‐
and cultural adaptation of health utilities index with appli‐ tient Rep Outcomes，2022，6（1）：42.
cation to pediatric oncology patients during neutropenia [38] HERDMAN M，KERR C，PAVESI M，et al. Testing the
and recovery in Turkey[J]. Pediatr Blood Cancer，2011，56 validity and responsiveness of a new cancer-specific

中国药房 2023年第34卷第4期 China Pharmacy 2023 Vol. 34 No. 4 · 455 ·